Multidrug-resistant TB

Multidrug-resistant TB (MDR-TB) begins when an antibiotic fails to eradicate all the bacteria that it targets, with the surviving bacteria producing resistance to that antibiotic and usually others at the same time. Primary Multidrug resistant, MDR-TB occurs in patients who was not earlier been infected with TB but who became infected with a strain which is resistant to the treatment. Acquired multidrug resistance for TB occurs in patients during treatment with a drug regimen that is not competent of killing the particular strain of TB with which they have been infected. MDR-TB requires treatment with second-line drugs, often four or more anti-TB drugs for a minimum of 6 months and a maximum for 18–24 months, if rifampin resistance has been identified in the specific strain of TB with which the patient has been infected. Under ideal program conditions, MDR-TB cure rates can approach 70%. In general, second-line drugs are less effective, more toxic and much more expensive than first-line drugs.

  • New drugs and new targets
  • New resistance mechanisms
  • Management of contacts of drug-resistant TB patients
  • MDR-TB treatment strategies in people living with HIV

Related Conference of Multidrug-resistant TB

November 21-22, 2019

2nd International Conference on Tropical and Infectious Diseases

Courtyard by Marriot Bali Seminyak Resort | Bali, Indonesia
November 25-26, 2019

2nd World Congress on Rare Diseases

Dubai, UAE
December 02-03, 2019

10th International Conference on Emerging Infectious Diseases

| Barcelona, Spain

Venue : Hesperia Barcelona del Mar

January 27-28, 2020

3rd Global Experts Meeting on Infectious Diseases

| Bangkok, Thailand
February 10-11, 2020

2nd Global Experts Meet on STD-AIDS and Infectious Diseases

Sydney, Australia
February 24-25, 2020

7th International Congress on Infectious Diseases

Berlin, Germany
March 11-12, 2020

8th International Conference on HIV AIDS STD & STIs

Barcelona, Spain
March 23-24, 2020

2nd World Congress on Advancements in Tuberculosis and Lung Diseases

Mar 18-19, 2020 | Tokyo, Japan
April 27-28, 2020

7th Global Congress on Rare Diseases & Orphan Drug

Istanbul, Turkey
July 22-23, 2020

10th World Congress on Rare Diseases and Orphan Drugs

Barcelona, Spain
August 19-20, 2020

European Summit on HIV, STD and STI

| Milan, Italy
September 28-29, 2020

13th Global Infections Conference

Singapore
October 05-06, 2020

12th Euro-Global Conference on Infectious Diseases

Vienna, Austria
December 06-07, 2021

3rd World Congress on Rare Diseases

Dubai, UAE

Multidrug-resistant TB Conference Speakers

Recommended Sessions

Related Journals

Are you interested in